Skip to content

The Impact of Braun Anastomosis with Different Lengths of Output Loop on the Major Clinical Outcomes After Pancreatectomy: A Prospective, Randomized, Controlled, Multicenter Clinical Study

The Impact of Braun Anastomosis with Different Lengths of Output Loop on the Major Clinical Outcomes After Pancreatectomy: A Prospective, Randomized, Controlled, Multicenter Clinical Study

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600116777
Enrollment
Unknown
Registered
2026-01-14
Start date
2025-07-03
Completion date
Unknown
Last updated
2026-01-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pancreatic cancer, bile duct cancer, ampullary cancer, benign/ borderline pancreatic tumors

Interventions

Extended Output Loop Group:Braun anastomosis with an extended output loop (30–40 cm) in pancreaticoduodenectomy
Standard Output Loop Group:Braun anastomosis with a standard-length output loop (10–15 cm) in pancreaticoduodenectomy

Sponsors

The First Affiliated Hospital of Guangxi Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Obtain informed consent signed by the patient or their legal representative, indicating willingness to participate in the study; 2. Compliance with the study protocol and follow-up procedures; 3. Patients aged between 18 and 80 years, regardless of gender; 4. No contraindications to surgical procedures, able to tolerate radical surgery, with an ECOG performance status of 0–1 and an ASA score of <=2; 5. Preoperative diagnosis of pancreatic cancer, bile duct cancer, ampullary cancer, or benign/borderline pancreatic tumors based on clinical symptoms, imaging studies, tumor markers, and other ancillary examinations, and recommended for PD after multidisciplinary consultation.

Exclusion criteria

Exclusion criteria: 1. Presence of other malignancies within the past year: patients with brain, lung, bone metastasis or peritoneal lymph node metastasis. 2. Severe dysfunction of the heart, lungs, liver, or kidneys. 3. Infection with HCV, HIV, or syphilis. 4. Pregnant or breastfeeding women. 5. Preoperative treatment with chemotherapy, immunotherapy, or targeted therapy. 6. Palliative surgery for the tumor. 7. Patient refusal to participate in the study.

Design outcomes

Primary

MeasureTime frame
Delayed gastric emptying;Pancreatic fistula;

Secondary

MeasureTime frame
Bile leakage ;Intra-abdominal infection;Bowel obstruction;Portal vein thrombosis;

Countries

China

Contacts

Public ContactZhang Wen

The First Affiliated Hospital of Guangxi Medical University

wenz@sr.gxmu.edu.cn+86 138 7810 8107

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026